CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Smart Choice MRI

At Smart Choice MRI, we put your comfort and convenience first. That doesn`t just mean giving you a scan using advanced GE technology and the expert interpretation by a Cleveland Clinic radiologist, for a fraction of what it would cost at a hospital. That means working with your schedule, offering early morning, evening, and weekend appointments, and doing whatever we can to make your scan a relaxing, comfortable experience.

Vantage BioTrials

Vantage BioTrials Inc. is a Dollard-Des-Ormeaux, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Grand Rapids Clinical Oncology Program

Grand Rapids Clinical Oncology Program is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

eb5 Corporation

eb5 Corporation is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

House Research Insitute

House Research Insitute is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.